Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Randomized double-blind placebo-controlled study of leptin administration after gastric bypass.

Korner J, Conroy R, Febres G, McMahon DJ, Conwell I, Karmally W, Aronne LJ.

Obesity (Silver Spring). 2013 May;21(5):951-6. doi: 10.1002/oby.20433.

2.

Roux-en-Y gastric bypass and calorie restriction induce comparable time-dependent effects on thyroid hormone function tests in obese female subjects.

Lips MA, Pijl H, van Klinken JB, de Groot GH, Janssen IM, Van Ramshorst B, Van Wagensveld BA, Swank DJ, Van Dielen F, Smit JW.

Eur J Endocrinol. 2013 Aug 28;169(3):339-47. doi: 10.1530/EJE-13-0339. Print 2013 Sep.

3.

Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial.

Zelissen PM, Stenlof K, Lean ME, Fogteloo J, Keulen ET, Wilding J, Finer N, Rössner S, Lawrence E, Fletcher C, McCamish M; Author Group.

Diabetes Obes Metab. 2005 Nov;7(6):755-61.

PMID:
16219020
4.

Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.

Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, Lubina JA, Patane J, Self B, Hunt P, McCamish M.

JAMA. 1999 Oct 27;282(16):1568-75.

PMID:
10546697
5.

Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass.

Stoeckli R, Chanda R, Langer I, Keller U.

Obes Res. 2004 Feb;12(2):346-50.

6.

Changes in measured resting energy expenditure after Roux-en-Y gastric bypass for clinically severe obesity.

Flancbaum L, Choban PS, Bradley LR, Burge JC.

Surgery. 1997 Nov;122(5):943-9.

PMID:
9369895
7.

Changes in gene expression profile in human subcutaneous adipose tissue during significant weight loss.

Leyvraz C, Verdumo C, Suter M, Paroz A, Calmes JM, Marques-Vidal PM, Giusti V.

Obes Facts. 2012;5(3):440-51. doi: 10.1159/000341137. Epub 2012 Jun 30.

8.

Metabolic adaptation following massive weight loss is related to the degree of energy imbalance and changes in circulating leptin.

Knuth ND, Johannsen DL, Tamboli RA, Marks-Shulman PA, Huizenga R, Chen KY, Abumrad NN, Ravussin E, Hall KD.

Obesity (Silver Spring). 2014 Dec;22(12):2563-9. doi: 10.1002/oby.20900. Epub 2014 Sep 19. Erratum in: Obesity (Silver Spring). 2016 Oct;24(10):2248.

9.

Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy--a prospective randomized trial.

Woelnerhanssen B, Peterli R, Steinert RE, Peters T, Borbély Y, Beglinger C.

Surg Obes Relat Dis. 2011 Sep-Oct;7(5):561-8. doi: 10.1016/j.soard.2011.01.044. Epub 2011 Mar 22.

PMID:
21429816
10.

Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass.

Gómez-Ambrosi J, Rodríguez A, Catalán V, Ramírez B, Silva C, Rotellar F, Gil MJ, Salvador J, Frühbeck G.

Clin Endocrinol (Oxf). 2008 Aug;69(2):208-15. Epub 2007 Dec 10.

PMID:
18081728
11.

Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study.

Foschi D, Corsi F, Lazzaroni M, Sangaletti O, Riva P, La Tartara G, Bevilacqua M, Osio M, Alciati A, Bianchi Porro G, Trabucchi E.

Int J Obes (Lond). 2007 Apr;31(4):707-12. Epub 2006 Sep 26.

PMID:
17006442
12.

Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity.

Ahmad NN, Pfalzer A, Kaplan LM.

Int J Obes (Lond). 2013 Dec;37(12):1553-9. doi: 10.1038/ijo.2013.38. Epub 2013 Apr 9.

13.

Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.

Kadera BE, Lum K, Grant J, Pryor AD, Portenier DD, DeMaria EJ.

Surg Obes Relat Dis. 2009 May-Jun;5(3):305-9. doi: 10.1016/j.soard.2009.02.007. Epub 2009 Feb 26.

PMID:
19460674
14.

A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion.

Lustig RH, Greenway F, Velasquez-Mieyer P, Heimburger D, Schumacher D, Smith D, Smith W, Soler N, Warsi G, Berg W, Maloney J, Benedetto J, Zhu W, Hohneker J.

Int J Obes (Lond). 2006 Feb;30(2):331-41.

15.

Weight loss and dietary intake after vertical banded gastroplasty and Roux-en-Y gastric bypass.

Brolin RE, Robertson LB, Kenler HA, Cody RP.

Ann Surg. 1994 Dec;220(6):782-90.

16.

Weight loss outcome of revisional bariatric operations varies according to the primary procedure.

Brolin RE, Cody RP.

Ann Surg. 2008 Aug;248(2):227-32. doi: 10.1097/SLA.0b013e3181820cdf.

PMID:
18650632
17.

Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for morbid obesity: case-control study.

Chouillard EK, Karaa A, Elkhoury M, Greco VJ; Intercontinental Society of Natural Orifice, Endoscopic, and Laparoscopic Surgery (i-NOELS).

Surg Obes Relat Dis. 2011 Jul-Aug;7(4):500-5. doi: 10.1016/j.soard.2011.01.037. Epub 2011 Mar 8.

PMID:
21459682
18.

Roux-en-Y gastric bypass achieves substantial resolution of migraine headache in the severely obese: 9-year experience in 81 patients.

Gunay Y, Jamal M, Capper A, Eid A, Heitshusen D, Samuel I.

Surg Obes Relat Dis. 2013 Jan-Feb;9(1):55-62. doi: 10.1016/j.soard.2012.01.009. Epub 2012 Jan 21.

PMID:
22445649
19.

Adipokine response in diabetics and nondiabetics following the Roux-en-Y gastric bypass: a preliminary study.

Whitson BA, Leslie DB, Kellogg TA, Maddaus MA, Buchwald H, Billington CJ, Ikramuddin S.

J Surg Res. 2007 Oct;142(2):295-300. Epub 2007 Jul 19.

PMID:
17640666
20.

Long-limb gastric bypass in the superobese. A prospective randomized study.

Brolin RE, Kenler HA, Gorman JH, Cody RP.

Ann Surg. 1992 Apr;215(4):387-95.

Supplemental Content

Support Center